<DOC>
	<DOCNO>NCT02522871</DOCNO>
	<brief_summary>A prospective , phased-pivotal , international randomize trial evaluate effectiveness OCS™ Liver preserve ass donor liver intend transplantation .</brief_summary>
	<brief_title>TransMedics ( OCS ) Liver Trial : Preserving Assessing Donor Livers Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Registered male female primary Liver transplant candidate Age ≥18 year old Signed : 1 ) write informed consent document 2 ) authorization use disclose protected health information Acute , fulminant liver failure Prior solid organ bone marrow transplant Chronic use hemodialysis diagnosis chronic renal failure , define chronic serum creatinine &gt; 3 mg/dl &gt; 2 week and/or require hemodialysis Multiorgan transplant Ventilator dependent Dependent &gt; 1 IV inotrope maintain hemodynamics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>